Kooth (KOO) Competitors

Kooth (LON:KOO) and Instem (LON:INS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, media sentiment, earnings and analyst recommendations.

Do analysts rate KOO or INS?

Kooth currently has a consensus target price of GBX 456.67, indicating a potential upside of 140.38%. Given Kooth's stronger consensus rating and higher possible upside, research analysts plainly believe Kooth is more favorable than Instem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kooth	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Instem	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the media favor KOO or INS?

In the previous week, Kooth had 3 more articles in the media than Instem. MarketBeat recorded 3 mentions for Kooth and 0 mentions for Instem. Kooth's average media sentiment score of 0.35 beat Instem's score of 0.00 indicating that Kooth is being referred to more favorably in the media.

Company	Overall Sentiment
Kooth	Neutral
Instem	Neutral

Do institutionals and insiders believe in KOO or INS?

65.0% of Kooth shares are owned by institutional investors. Comparatively, 65.9% of Instem shares are owned by institutional investors. 17.3% of Kooth shares are owned by company insiders. Comparatively, 30.0% of Instem shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Is KOO or INS more profitable?

Kooth has a net margin of 7.89% compared to Instem's net margin of 5.50%. Kooth's return on equity of 18.59% beat Instem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kooth	7.89%	18.59%	10.12%
Instem	5.50%	6.35%	4.62%

Which has higher earnings & valuation, KOO or INS?

Kooth has higher earnings, but lower revenue than Instem. Instem is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kooth	£50.72M	1.37	£4.00M	£10.64	17.85
Instem	£61.63M	0.00	£3.34M	£0.14	N/A

Which has more volatility & risk, KOO or INS?

Kooth has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500. Comparatively, Instem has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500.

Summary

Kooth beats Instem on 11 of the 15 factors compared between the two stocks.